Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMVI as a Determinant of Metastasis in Colorectal Cancer

NCT06646341 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT06646341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06646341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMVI as a Determinant of Metastasis in Colorectal Cancer
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
December 31, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer